# GlaxoSmithKline Biologicals SA – FDA Inspection, Jan 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/70cb7ce5-0715-4ec4-8b61-c997bb03b824
Source feed: FDA_Inspections

> FDA inspection 1007184 of GlaxoSmithKline Biologicals SA, January 27, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1007184
- Company Name: GlaxoSmithKline Biologicals SA
- Inspection Date: 2017-01-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1304664 - 2026-02-27](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/a737c389-4e6a-4fcc-94cb-27544c5ade52)
- FDA Inspection 1215345 - 2023-06-23
- [FDA Inspection 1099397 - 2019-06-24](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/beae85df-4d31-45f7-93a5-448b49902f50)
- FDA Inspection 900625 - 2014-10-02
- FDA Inspection 818683 - 2012-10-05

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/cynthia-jim/e0f1c8a7-d787-442a-911c-61e37cd806a6)
- [Gene D. Arcy](https://www.keypedia.com/people/gene-d-arcy/a2def947-65fb-4056-84e2-1f89cf944cf0)
- [Issuing Officer](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb)

Company: https://www.keypedia.com/companies/glaxosmithkline-biologicals-sa/ef569005-49c7-4bf9-b3f1-7814705bec8e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
